0512.HK HKSE
Grand Pharmaceutical Group Limited
1W: -0.6%
1M: -1.2%
3M: -10.9%
YTD: -39.2%
1Y: -41.8%
3Y: +20.3%
5Y: -16.4%
HK$4.72 ($0.60)
-0.07 (-1.56%)
Weekly Expected Move ±3.9%
HK$4
HK$5
HK$5
HK$5
HK$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.9B
-21.7% ▼
5Y CAGR: +9.8%
Capital Expenditures
$622M
-25.0% ▼
5Y CAGR: +0.7%
Free Cash Flow
$1.3B
-33.8% ▼
5Y CAGR: +16.8%
Dividends Paid
$910M
-83.2% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$1M
+101.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.8B | $2.4B | $2.1B | $1.9B | $2.9B |
| Depreciation & Amort. | $287M | $340M | $395M | $392M | $504M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$228M | -$299M | -$893M | -$123M | -$420M |
| Other Non-Cash Items | -$76M | -$438M | $336M | $276M | -$1.0B |
| Operating Cash Flow | $1.8B | $2.0B | $1.9B | $2.4B | $1.9B |
| — Investing Activities — | |||||
| Capital Expenditures | -$467M | -$627M | -$1.7B | -$488M | -$581M |
| Acquisitions (Net) | -$9M | -$267M | -$267M | -$170M | -$1.2B |
| Investment Purchases | -$1.4B | -$1.4B | -$2.1B | -$1.6B | -$217M |
| Investment Sales | $33M | $219M | $1.4B | $1.7B | $21M |
| Other Investing | -$160M | $325M | $0 | $81M | -$42M |
| Investing Cash Flow | -$2.1B | -$1.8B | -$2.6B | -$516M | -$2.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | $241M | $365M | $917M | -$1.1B | $1.2B |
| Stock Repurchased | $0 | -$144M | -$44M | -$81M | $0 |
| Dividends Paid | -$324M | -$390M | -$390M | -$497M | -$910M |
| Other Financing | -$31M | -$165M | -$18M | -$257M | -$232M |
| Financing Cash Flow | $900M | -$333M | $464M | -$1.9B | $30M |
| Net Change in Cash | $687M | -$84M | -$315M | -$104M | $1M |
| Cash End of Period | $1.9B | $1.8B | $1.4B | $1.3B | $1.3B |
| Free Cash Flow | $1.3B | $1.5B | $246M | $1.9B | $1.3B |